According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ31.58 Million a decrease over its 2022 earnings that were of -ยฃ29.82 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.